This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
May 2023, the Department of Financial & Professional Regulation (IDFPR) announced that Illinois was switching its cannabis seed-to-sale tracking system from BioTrack to Metrc and listed this transition as an Essential Projects in the FY2023 Annual Cannabis Report and again in the FY2024 report.
Friday, the Illinois Department of Financial & Professional Regulation (IDFPR) released its Annual Cannabis Report for fiscal year 2023. The 20-page report included a summary, 2023 accomplishments, goals for fiscal year 2024, and several charts and statistics. This goal was again listed as one of the Essential Projects for FY2024.
Effective July of 2023, the new legislation aims to regulate medical and recreational cannabis as similarly as possible, holding them to the same standards. Additionally, everything will be tracked from seed to sale as it is now, ensuring that consumers can have confidence in the quality and safety of the product they are buying.
Allowed formats include flowers, concentrates, edibles, transdermal products, seeds, and seedlings.” On July 6, 2022, Washington, D.C. implemented a revolutionary emergency amendment to its medical cannabis program. The Medical Marijuana Self-Certification Temporary Amendment Act of 2022 currently permits D.C. These changes to D.C.’s
The Oneida Indian Nation will oversee the entire business vertical from “seed to sale.”. Retail locations, which will be announced at a later date and located exclusively on Nation lands, are projected to open in late 2023. The entire cannabis operation, from seed to sale, will be operated by the Oneida Indian Nation.
Effective July of 2023, the new legislation aims to regulate medical and recreational cannabis as similarly as possible, holding them to the same standards. Additionally, everything will be tracked from seed to sale as it is now, ensuring that consumers can have confidence in the quality and safety of the product they are buying.
Similarly, the MRTA requires the CCB “[t]o fix by rule and regulation the standards and requirements of cultivation, processing, packaging, marketing, and sale of. ” The CCB intends to address the sale of such products in the adult-use regulations. no later than six months after the effective date of the MRTA.”
The Oregon legislative Task Force on Cannabis-Derived Intoxicants and Illegal Cannabis Production is exploring potential reforms to the state’s regulation of cannabinoid products and legislation for 2023 to combat what law enforcement believes is an increase in illicit marijuana production. concentration threshold.
First, a manufacturer can make an independent GRAS conclusion by determining a substance is generally recognized, “among experts qualified by scientific training and experience to evaluate its safety.” Delta-8 THC and other Artificially Derived Cannabinoids. 21 CFR 170.230, 170.235, and 170.255.
As the Californian cannabis industry gains momentum, an increasingly number of people are expressing interest to participate in the cannabis movement. This is especially true in the new normal, where cannabis businesses were deemed “essential” in era of Covid-19. are at least somewhat aware of the regulatory framework. How do I get a license?
Cannabis NYC will plant the seeds for the economy of tomorrow by helping New Yorkers apply for licenses and understand how to open and successfully run a business, while simultaneously rolling equity into our economy by giving those who have been justice-involved and those with a cannabis conviction a chance to succeed.
In November 2020 the ECJ concluded that CBD extracted from the Cannabis sativa plant in its entirety — and not solely from its fiber and seeds — cannot be regarded as a narcotic drug. For further information on the novel food application process see our latest post on European CBD Sales: Securing a Novel Food Authorization.
According to a recent study by Cowen , the sales of these products are expected to reach $16 billion by 2025. Europe has also experienced a huge uptick in the sales of these products, which are expected to reach nearly $1.7 billion by 2023. Thanks to globalization, this sudden boom is not contained within the U.S.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content